Caimi G
Istituto di Clinica Medica e Malattie Cardiovascolari, Università degli Studi di Palermo, Italy.
Clin Hemorheol Microcirc. 1997 May-Jun;17(3):199-208.
In subjects with essential hypertension we evaluated, respectively, the red cell membrane protein lateral mobility (obtained marking intact red blood cells with pyrene-3-maleimide (3-PM)), the erythrocyte membrane fluidity (obtained marking intact erythrocytes with 10-(1-pyrene) decanoic acid), the red cell membrane transverse fluidity gradient (obtained marking intact red blood cells with a set of fatty acid fluorescent probes (2-AP, 6-AS, 9-AS, 12-AS)), the platelet membrane fluidity (obtained marking intact and unstimulated platelets with 1,6-diphenyl-1,3,5-hexatriene (DPH) and with 1-(4-(trimethylamino)phenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH)) and the polymorphonuclear membrane fluidity (obtained marking intact and unstimulated polymorphonuclear cells with TMA-DPH). From the obtained data it is evident that: (1) red cell membrane protein lateral mobility does not distinguish normals from hypertensives; (2) erythrocyte membrane fluidity and red cell membrane transverse fluidity gradient clearly discriminate normals from hypertensives; (3) platelet membrane fluidity differentiates normals from hypertensives only when DPH is used as fluorescent probe; (4) polymorphonuclear membrane fluidity does not distinguish normals from hypertensives. Our results show that in essential hypertension a different behaviour of the membrane dynamic properties in the circulating blood cells is evident.
在原发性高血压患者中,我们分别评估了红细胞膜蛋白侧向流动性(用芘-3-马来酰亚胺(3-PM)标记完整红细胞获得)、红细胞膜流动性(用10-(1-芘基)癸酸标记完整红细胞获得)、红细胞膜横向流动性梯度(用一组脂肪酸荧光探针(2-AP、6-AS、9-AS、12-AS)标记完整红细胞获得)、血小板膜流动性(用1,6-二苯基-1,3,5-己三烯(DPH)和1-(4-(三甲基氨基)苯基)-6-苯基-1,3,5-己三烯(TMA-DPH)标记完整且未受刺激的血小板获得)以及多形核细胞膜流动性(用TMA-DPH标记完整且未受刺激的多形核细胞获得)。从获得的数据可以明显看出:(1)红细胞膜蛋白侧向流动性无法区分正常人和高血压患者;(2)红细胞膜流动性和红细胞膜横向流动性梯度能清楚地区分正常人和高血压患者;(3)仅当使用DPH作为荧光探针时,血小板膜流动性才能区分正常人和高血压患者;(4)多形核细胞膜流动性无法区分正常人和高血压患者。我们的结果表明,在原发性高血压中,循环血细胞中膜动力学特性的行为存在差异。